Nouveau Life Pharmaceuticals Inc
Nouveau Life Pharmaceuticals, Inc., a development stage company, engages in providing a platform for remote senior care. The company also enables users to monitor patients in real time and access detailed patient information digitally; and its platform is designed to detect emergencies proactively and facilitate non-face-to-face care services. In addition, the company is developing robotic and ar… Read more
Nouveau Life Pharmaceuticals Inc (NOUV) - Total Liabilities
Latest total liabilities as of March 2023: $103.26K USD
Based on the latest financial reports, Nouveau Life Pharmaceuticals Inc (NOUV) has total liabilities worth $103.26K USD as of March 2023.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Nouveau Life Pharmaceuticals Inc - Total Liabilities Trend (2002–2006)
This chart illustrates how Nouveau Life Pharmaceuticals Inc's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Nouveau Life Pharmaceuticals Inc Competitors by Total Liabilities
The table below lists competitors of Nouveau Life Pharmaceuticals Inc ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Aerofoam Metals Inc
PINK:AFML
|
USA | $12.72 Million |
|
Proliance International Inc
PINK:PLNTQ
|
USA | $133.49 Million |
|
Blue Gem Enterprise
PINK:BGEM
|
USA | $425.87K |
|
Quick-Med Technologies Inc
PINK:QMDT
|
USA | $9.78 Million |
|
Discovery Minerals
PINK:DSCR
|
USA | $959.41K |
|
American Leisure Holdings Inc
PINK:AMLH
|
USA | $1.02 Million |
|
Kunekt Corporation
PINK:KNKT
|
USA | $208.32K |
|
CVF Technologies Corporation
PINK:CNVT
|
USA | $2.76 Million |
Liability Composition Analysis (2002–2006)
This chart breaks down Nouveau Life Pharmaceuticals Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 4.25 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | -1.08 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 13.39 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Nouveau Life Pharmaceuticals Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Nouveau Life Pharmaceuticals Inc (2002–2006)
The table below shows the annual total liabilities of Nouveau Life Pharmaceuticals Inc from 2002 to 2006.
| Year | Total Liabilities | Change |
|---|---|---|
| 2006-12-31 | $1.01 Million | +12.99% |
| 2005-12-31 | $897.85K | -6.59% |
| 2004-12-31 | $961.17K | +13.39% |
| 2003-12-31 | $847.70K | +5.92% |
| 2002-12-31 | $800.31K | -- |